• 3-Fucosyllactose (3-FL)
  • 3-Fucosyllactose (3-FL)

3-Fucosyllactose (3-FL)

Brief introduction

Human Milk Oligosaccharides (HMOs) are the third most abundant solid component in human milk, following lactose and fats. HMOs are complex carbohydrates composed of 3 to 10 monosaccharide units, including glucose, galactose, N-acetylglucosamine, fucose, and sialic acid. The concentration of HMOs in human milk ranges from 5 to 20 g/L, making them a crucial component of early infant nutrition.

The following Human Milk Oligosaccharides (HMOs) have been approved for use in food products in the United States and the European Union. They are also the most abundant HMOs in human milk:

Lacto-N-tetraose (LNT)

Lacto-N-neotetraose (LNnT)

2'-Fucosyllactose (2'-FL)

3-Fucosyllactose (3-FL)

  • 3-Fucosyllactose (3-FL)

Application

HMOs are essential bioactive components in human milk, offering numerous health benefits such as promoting gut health, enhancing immunity, supporting brain development, reducing inflammation, preventing infections, and potentially fighting cancer. They are widely used in infant formula, functional foods, and medical nutrition.

 

(1) Promotes Gut Health

HMOs act as prebiotics, selectively promoting the growth of beneficial bacteria (e.g., Bifidobacteria) and inhibiting the colonization of pathogens, thereby maintaining gut microbiota balance.

(2) Enhances Immune System

HMOs prevent pathogen infections by competing with pathogens for binding sites on gut cell surfaces. They also modulate immune cell functions and enhance immune responses.

(3) Supports Brain Development

Sialic acid-containing HMOs (e.g., 3'-SL and 6'-SL) are involved in neuronal formation and synaptic plasticity, playing a critical role in infant brain development.

(4) Anti-inflammatory Effects

HMOs reduce intestinal inflammation and alleviate symptoms of inflammatory bowel disease (IBD).

(5) Prevents Infections

HMOs reduce the risk of infections by preventing pathogens (e.g., bacteria and viruses) from binding to host cells.

(6) Potential Anti-cancer Effects

Studies suggest that HMOs may have anti-cancer effects by modulating immune responses and inhibiting tumor cell growth.

 

References

  1. Okburan G, Kızıler S. Human milk oligosaccharides as prebiotics. Pediatr Neonatol. 2023 May;64(3):231-238.
  2. Dinleyici M, Barbieur J, Dinleyici EC, Vandenplas Y. Functional effects of human milk oligosaccharides (HMOs). Gut Microbes. 2023 Jan-Dec;15(1):2186115.
  3. Moubareck CA. Human Milk Microbiota and Oligosaccharides: A Glimpse into Benefits, Diversity, and Correlations. Nutrients. 2021 Mar 29;13(4):1123.
  4. Vandenplas Y, Berger B, Carnielli VP, Ksiazyk J, Lagström H, Sanchez Luna M, Migacheva N, Mosselmans JM, Picaud JC, Possner M, Singhal A, Wabitsch M. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula. Nutrients. 2018 Aug 24;10(9):1161.
  5. Andreas NJ, Kampmann B, Mehring Le-Doare K. Human breast milk: A review on its composition and bioactivity. Early Hum Dev. 2015 Nov;91(11):629-35.
  6. Tytgat HLP, Binia A, Austin S, Grathwohl D, Sprenger N. Human Milk Oligosaccharides, Important Milk Bioactives for Child Health: A Perspective. Nestle Nutr Inst Workshop Ser. 2023;97:30-40.
  7. Zhu L, Li H, Luo T, Deng Z, Li J, Zheng L, Zhang B. Human Milk Oligosaccharides: A Critical Review on Structure, Preparation, Their Potential as a Food Bioactive Component, and Future Perspectives. J Agric Food Chem. 2023 Nov 1;71(43):15908-15925.
  8. Kijner S, Kolodny O, Yassour M. Human milk oligosaccharides and the infant gut microbiome from an eco-evolutionary perspective. Curr Opin Microbiol. 2022 Aug;68:102156.
  9. Zhang B, Li LQ, Liu F, Wu JY. Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function. Carbohydr Polym. 2022 Jan 15;276:118738.
  10. Szajewska H. Selected Human Milk Oligosaccharides Added to Infant Formulas for Term Infants. Nestle Nutr Inst Workshop Ser. 2021;96:149-159.
  11. Donovan SM, Comstock SS. Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Ann Nutr Metab. 2016;69 Suppl 2(Suppl 2):42-51.
  12. Salamone M, Di Nardo V. Effects of human milk oligosaccharides (HMOs) on gastrointestinal health. Front Biosci (Elite Ed). 2020 Mar 1;12(1):183-198.
  13. Zhang S, Li T, Xie J, Zhang D, Pi C, Zhou L, Yang W. Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota. Microb Cell Fact. 2021 May 28;20(1):108.
  14. Barnett DJM, Endika MF, Klostermann CE, Gu F, Thijs C, Nauta A, Schols HA, Smidt H, Arts ICW, Penders J. Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study. Gut Microbes. 2023 Jan-Dec;15(1):2164152.
  15. Lis-Kuberka J, Orczyk-Pawiłowicz M. Sialylated Oligosaccharides and Glycoconjugates of Human Milk. The Impact on Infant and Newborn Protection, Development and Well-Being. Nutrients. 2019 Feb 1;11(2):306.
Leave a message
FirstName*
LastName*
Email*
Message*
We use Cookie to improve your online experience. By continuing browsing this website, we assume you agree our use of Cookie.